Nursing Home Laboratory and Diagnostic Services

Laboratory and diagnostic services in nursing homes encompass the collection, analysis, and clinical interpretation of biological specimens and imaging studies ordered for residents in long-term care settings. These services operate under a distinct regulatory framework that governs facility responsibilities, provider qualifications, and care planning integration. Understanding how diagnostic services function within skilled nursing facilities is essential for evaluating care quality, billing accuracy, and compliance with federal conditions of participation.

Definition and scope

Laboratory and diagnostic services in the nursing home context include any test or procedure used to detect, monitor, or rule out a medical condition in a resident. The scope spans point-of-care testing performed at the bedside, specimens sent to off-site reference laboratories, portable diagnostic imaging, and electrocardiography.

Under the federal conditions of participation at 42 CFR Part 483, Subpart B (§483.50), skilled nursing facilities (SNFs) must provide or arrange for laboratory services to meet the needs of residents. The regulation distinguishes between:

• Routine laboratory services — complete blood count, basic metabolic panel, urinalysis, cultures, coagulation studies, lipid panels, and thyroid function tests
• Specialized diagnostic services — services beyond standard panels, including microbiology sensitivities, advanced pathology, or genetic assays, typically referred to outside laboratories
• Portable diagnostic studies — electrocardiography (ECG), portable radiography, and ultrasound performed on-site by contracted or mobile vendors
• Point-of-care (POC) testing — rapid glucose monitoring, rapid influenza antigen tests, and urine dipstick testing performed by nursing staff at the unit level

The Clinical Laboratory Improvement Amendments of 1988 (CLIA), administered jointly by the Centers for Medicare & Medicaid Services (CMS), the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC), classify laboratories by test complexity: waived, moderate complexity, and high complexity. Nursing homes conducting any testing beyond waived-complexity POC assays must hold an appropriate CLIA certificate.

How it works

The diagnostic service pathway in a nursing facility follows a structured sequence that connects clinical observation to care plan modification.

1. Clinical trigger — A nurse, certified nursing assistant, or visiting clinician identifies a symptom, decline in functional status, or scheduled monitoring need. The nursing home medical director or attending physician is notified.
2. Order entry — A licensed physician, nurse practitioner, or physician assistant issues a written or electronic order specifying the test, specimen type, and urgency. Nurse practitioners and physician assistants authorized under 42 CFR §483.30 may enter orders within their state scope of practice. More detail on their roles is available on the Nurse Practitioner and Physician Assistant Roles in Nursing Homes page.
3. Specimen collection or study scheduling — Nursing staff collect blood, urine, wound cultures, or other specimens following facility protocol. Mobile diagnostic vendors are scheduled for ECG, portable X-ray, or ultrasound.
4. Transport and processing — Specimens are transported under chain-of-custody conditions to either an in-house CLIA-certified laboratory or a contracted reference laboratory. Transport temperature requirements, labeling standards, and time-to-processing windows are governed by CLIA and laboratory-specific accreditation standards from the College of American Pathologists (CAP) or the Joint Commission.
5. Result reporting and critical value notification — Reference laboratories transmit results electronically or by fax. Critical values — results outside life-threatening thresholds — must be communicated to the ordering clinician within a defined timeframe. CMS Survey & Certification guidance requires facilities to have written policies specifying critical value escalation procedures.
6. Clinical interpretation and care plan integration — The ordering clinician reviews results and issues follow-up orders. Findings are incorporated into the resident's care plan and interdisciplinary team documentation through the Minimum Data Set process (see Minimum Data Set and Resident Assessment Instruments).
7. Billing and documentation — Laboratory services billed to Medicare Part A during a SNF stay are included in the SNF consolidated billing requirement under 42 U.S.C. §1395yy. Reference laboratory claims during Part A stays must be submitted through the SNF, not independently.

Common scenarios

Laboratory and diagnostic services are triggered by four primary clinical situations in nursing homes:

Infection workup — Fever, altered mental status, or elevated white blood cell count prompts blood cultures, urine culture and sensitivity, and chest X-ray. Given that urinary tract infections are among the most frequently diagnosed conditions in long-term care residents, infection control and prevention protocols intersect directly with laboratory ordering practices.

Chronic disease monitoring — Residents with diabetes require hemoglobin A1c testing at intervals recommended by the American Diabetes Association, as well as point-of-care glucose monitoring. Diabetes management in nursing home residents relies heavily on a structured laboratory schedule integrated into the care plan.

Medication safety monitoring — Anticoagulants (warfarin, requiring INR monitoring), diuretics (electrolyte panels), and certain antibiotics (aminoglycosides, requiring serum drug levels and creatinine) necessitate scheduled laboratory surveillance. This work intersects with medication management in nursing homes.

Acute decline and transfer evaluation — When a resident experiences a sudden change in condition, a diagnostic battery guides the decision to treat in place or transfer to a hospital. The troponin assay, portable ECG, and complete metabolic panel are commonly ordered in this scenario, which connects to nursing home readmission and hospital transfer protocols.

Decision boundaries

The distinction between services performed within the SNF versus those requiring external referral follows test complexity classification under CLIA.

A facility that operates only waived testing equipment does not require the same CLIA infrastructure as one running on-site hematology analyzers. Most nursing homes contract with a regional reference laboratory for the majority of specimen-based testing and hold only a CLIA Certificate of Waiver for bedside POC assays.

The consolidated billing rule creates an important boundary for Medicare Part A beneficiaries: during the SNF qualifying stay, nearly all Part B laboratory services are bundled into the SNF per diem rate (CMS Consolidated Billing guidance). Services that fall outside consolidated billing — including certain clinical diagnostic laboratory tests carved out by CMS — must be billed separately, requiring careful coordination between the SNF, reference laboratory, and billing staff.

Facilities are also required under 42 CFR §483.50(b) to promptly notify the resident and responsible party of laboratory results and to document that notification. This obligation intersects with resident rights and medical decision-making in nursing homes, particularly for residents with advance directives that limit certain diagnostic interventions.

References

• 42 CFR Part 483, Subpart B — Requirements for Long-Term Care Facilities (eCFR)
• Centers for Medicare & Medicaid Services (CMS) — Clinical Laboratory Improvement Amendments (CLIA)
• CMS SNF Consolidated Billing Guidance
• Centers for Disease Control and Prevention (CDC) — CLIA Program Overview
• Food and Drug Administration (FDA) — CLIA Categorization
• College of American Pathologists (CAP) — Laboratory Accreditation Program
• The Joint Commission — Laboratory Accreditation
• [42 U.S.C.